<DOC>
	<DOC>NCT02635412</DOC>
	<brief_summary>This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta.</brief_summary>
	<brief_title>Delivery Timing in Morbidly Adherent Placentas: a Randomized, Controlled Trial</brief_title>
	<detailed_description>This is a randomized controlled trial to investigate the optimal timing of delivery in clinically stable women with a suspected morbidly adherent placenta dispositioned for a scheduled delivery. The primary outcome will be assessed by comparing the composite neonatal morbidity and composite maternal morbidity between the two groups (delivery at 34 versus 36 weeks gestational age).</detailed_description>
	<mesh_term>Placenta Accreta</mesh_term>
	<criteria>Women with monographically morbidly adherent placenta with or without a placenta previa. Scheduled delivery via cesarean hysterectomy Delivery planned prior to 36 weeks (e.g. nonreassuring fetal status, preterm labor, severe preeclampsia, other medical/fetal indication for delivery as determined by the managing physician).</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Placenta</keyword>
	<keyword>Accreta</keyword>
	<keyword>Morbidly</keyword>
	<keyword>Adherent Placenta</keyword>
</DOC>